Kazia Therapeutics (KZIA) Retained Earnings (2009 - 2025)

Kazia Therapeutics has reported Retained Earnings for 15 years, with the latest figure at $3.4 million in Q4 2025.

• For the quarter ending Q4 2025, Retained Earnings rose 48.84% year-over-year to $3.4 million; the trailing twelve-month figure through Dec 2025 stood at $3.4 million (up 48.84% YoY), and the FY2025 full-year result was $2.0 million, down 13.32% from the prior year.
• Retained Earnings for Q4 2025 stood at $3.4 million, up from $2.0 million in the prior quarter.
• The five-year high for Retained Earnings was $3.4 million in Q4 2025, with the low at -$34.0 million in Q2 2021.
• Historically, Retained Earnings has averaged -$1.4 million across 5 years, with a median of $2.3 million in 2022.
• Annual changes were most pronounced in 2021 — Retained Earnings slumped 4971.99% — and 2022, when it surged 129.72%.
• Kazia Therapeutics' Retained Earnings stood at $983709.8 in 2021, then surged by 129.72% to $2.3 million in 2022, then rose by 15.63% to $2.6 million in 2023, then retreated by 13.82% to $2.3 million in 2024, then soared by 48.84% to $3.4 million in 2025.
• The last three Retained Earnings figures came in at $3.4 million (Q4 2025), $2.0 million (Q2 2025), and $2.3 million (Q4 2024), per Business Quant data.